A systematic review of clinical practice guidelines for childhood glaucoma.


Journal

BMJ open ophthalmology
ISSN: 2397-3269
Titre abrégé: BMJ Open Ophthalmol
Pays: England
ID NLM: 101714806

Informations de publication

Date de publication:
2022
Historique:
received: 01 11 2021
accepted: 18 01 2022
entrez: 9 2 2022
pubmed: 10 2 2022
medline: 10 2 2022
Statut: epublish

Résumé

To conduct a systematic review to identify and critically appraise clinical practice guidelines on the assessment, diagnosis and management of childhood glaucoma. A systematic literature search of databases and professional websites for clinical practice guidelines published on eye conditions between 2010 and April 2020 in English was conducted. Identified guidelines were screened for relevance to childhood glaucoma and exclusion criteria applied. Guidelines that passed the screening and quality appraisal with the Appraisal of Guidelines for Research and Evaluation II (AGREE II) tool and, if they achieved a mean score of ≥45 and ≥3 on subsets of 9 and 5 AGREE II items, respectively, were selected for inclusion and data extracted using a standardised form. Following screening and critical appraisal, three guidelines were included for data extraction. None of the three guidelines was specifically developed for childhood glaucoma. A consistent recommendation was that children should undergo some form of eye screening examination or a comprehensive eye assessment to detect paediatric eye disease. Children at high risk of childhood glaucoma should undergo additional screening. One clinical practice guideline recommended interventions for childhood glaucoma consisting of tube surgery and topical beta-blockers or carbonic anhydrase inhibitors. Recommended interventions for childhood glaucoma were based on low-quality to moderate-quality evidence or expert opinion. Based on our selection criteria, we did not identify any high-quality clinical practice guidelines specifically targeted at childhood glaucoma. This is compounded by the lack of high-quality evidence on childhood glaucoma.

Identifiants

pubmed: 35136841
doi: 10.1136/bmjophth-2021-000933
pii: bmjophth-2021-000933
pmc: PMC8804684
pii:
doi:

Types de publication

Journal Article Systematic Review

Langues

eng

Pagination

e000933

Subventions

Organisme : World Health Organization
ID : 001
Pays : International

Informations de copyright

© Author(s) (or their employer(s)) 2022. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ.

Déclaration de conflit d'intérêts

Competing interests: None declared.

Références

Arch Phys Med Rehabil. 2019 Nov;100(11):2205-2211
pubmed: 31207218
Ophthalmic Epidemiol. 2008 May-Jun;15(3):176-82
pubmed: 18569813
Ophthalmol Glaucoma. 2021 Sep 23;:
pubmed: 34562634
Graefes Arch Clin Exp Ophthalmol. 2020 Aug;258(8):1579-1586
pubmed: 32483675
Acta Ophthalmol Suppl (Oxf ). 2012 Dec;(251):1-40
pubmed: 23279889
Eye (Lond). 1993;7 ( Pt 4):580-3
pubmed: 8253243
Arch Ophthalmol. 2010 Apr;128(4):478-82
pubmed: 20385945
Med Wieku Rozwoj. 2007 Apr-Jun;11(2 Pt 2):193-216
pubmed: 17965470
Curr Opin Ophthalmol. 2013 Mar;24(2):136-43
pubmed: 23542350
Arch Ophthalmol. 2002 Nov;120(11):1470-6
pubmed: 12427059
Cochrane Database Syst Rev. 2020 Aug 25;8:CD008213
pubmed: 32816311
J AAPOS. 2012 Dec;16(6):501-7
pubmed: 23237744
Ophthalmology. 2018 Jan;125(1):P184-P227
pubmed: 29108745
Indian J Ophthalmol. 2018 Jul;66(7):889-892
pubmed: 29941725
CMAJ. 2010 Dec 14;182(18):E839-42
pubmed: 20603348
Arch Ophthalmol. 1998 Apr;116(4):545-6
pubmed: 9565065
Invest Ophthalmol Vis Sci. 2007 Sep;48(9):4100-6
pubmed: 17724193
BMJ Open Ophthalmol. 2020 Aug 11;5(1):e000533
pubmed: 32821853
Pediatrics. 2016 Jan;137(1):28-30
pubmed: 29756730
Eye (Lond). 2007 Jun;21(6):764-74
pubmed: 16575414
Eye (Lond). 2019 Apr;33(4):659-667
pubmed: 30518976
Am J Ophthalmol. 2019 Sep;205:106-114
pubmed: 31082348

Auteurs

Gareth Lingham (G)

Centre for Eye Research Ireland, Technological University Dublin, Dublin, Ireland gareth.lingham@tudublin.ie.
Centre for Ophthalmology and Visual Science, The University of Western Australia, Perth, Western Australia, Australia.

Sahil Thakur (S)

Singapore Eye Research Institute, Singapore.

Sare Safi (S)

Ophthalmic Research Centre, Research Institute for Ophthalmology and Vision Science, Shahid Beheshti University of Medical Sciences, Tehran, Iran.
World Health Organization Collaborating Centre for the Eye Care and Prevention of Blindness, Tehran, Iran.

Iris Gordon (I)

International Centre for Eye Health, London School of Hygiene & Tropical Medicine, London, UK.

Jennifer R Evans (JR)

International Centre for Eye Health, London School of Hygiene & Tropical Medicine, London, UK.

Stuart Keel (S)

Vision and Blindness Prevention Programme, World Health Organization, Geneva, Switzerland.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH